Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

SleepCheckRx app for OSA screening receives FDA clearance

On July 6, 2022, ResApp Health Limited announced that SleepCheckRx received FDA 510(k) clearance as prescription-only software as a medical device. It is intended to record respiratory patterns during sleep to pre-screen patients for obstructive sleep apnea (OSA). About SleepCheckRx SleepCheckRx is an at-home [...]

2024-09-24T21:34:09-05:00July 7th, 2022|Industry|

Cerebra Sleep System receives FDA 510(k) clearance

On July 7, 2022, Cerebra Medical announced it received FDA 510(k) clearance for its Cerebra Sleep System, a lab-quality in-home polysomnography (PSG) that is fully self-applied by the patient, without the presence of a technician. About Cerebra Sleep System The Cerebra Sleep System [...]

2024-09-24T21:37:16-05:00July 7th, 2022|Industry|

FDA clears Fisher & Paykel Evora Full mask for OSA

On April 19, 2022, Fisher & Paykel Healthcare announced the U.S. launch of F&P Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment. The mask received FDA 510(k) clearance. About F&P Evora Full According to the company’s press release, the [...]

2024-09-24T21:52:48-05:00April 20th, 2022|Industry|

FDA clears Fitbit feature to detect A-fib

Google announced April 11, 2022, that Fitbit received FDA clearance for its photoplethysmography (PPG) algorithm to identify atrial fibrillation (A-fib). The algorithm will power Fitbit’s new irregular heart rhythm notification feature. About Fitbit’s PPG algorithm Fitbit’s PPG algorithm passively assesses heart rate while [...]

2024-09-24T21:54:24-05:00April 12th, 2022|Industry|

FDA clears wireless patch to detect sleep apnea

Wesper announced on Jan. 25, 2022, that it received FDA clearance for its Wesper Lab system, which assists trained personnel in the diagnosis of obstructive sleep apnea (OSA) with data from a wireless patch component. About Wesper Lab Wesper Lab is a digital [...]

2024-09-24T21:56:04-05:00January 26th, 2022|Industry|

Idorsia receives FDA approval of QUVIVIQ for insomnia

On Jan. 10, 2022, Idorsia announced that the FDA approved QUVIVIQ (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. About QUVIVIQ QUVIVIQ is a prescription medication indicated for [...]

2024-09-24T21:57:42-05:00January 11th, 2022|Industry|

Acurable receives FDA clearance for home sleep apnea testing device

On Nov. 30, 2021, Acurable announced it received FDA 510(k) clearance for its AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnea (OSA) in adults. About AcuPebble SA100 AcuPebble SA100 senses, records and interprets a patient’s [...]

2024-09-24T21:58:28-05:00December 1st, 2021|Industry|
Go to Top